Work

Abstract CT111: A phase 1, first-in-human study of IB-T101, an OUTLAST™ CAR-T product for the treatment of CD70-positive clear cell renal carcinoma

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct111

Authors: Bo Liu, Warren Anderson, Mathew Esquivel, Adam Pecoraro, Kate Fagan-Solis, Yuning Lei, Jun Cui, Yarong Liu, Kevin Carbajal, Maximilian Richter, Matthias Schroff

Institutions: Tongji Hospital, Huazhong University of Science and Technology, Grit Biotechnology (China)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822112

Cites:

Cited by:

Related to: 10